Company intelligence / Profile preview

iPS Portal

Ownership: Private
Employees: ~20
Development stage: Commercial

Overview

iPS Portal specializes in contract testing of induced pluripotent stem (iPS) cells and supports the development and commercialization of cell technology, including regenerative medicine applications. The company also assists start-ups in the cell-tech space and has contributed to establishing companies focused on corneal regenerative medicine and fertility treatments[2][3].

Modalities: Induced pluripotent stem cell derived therapyCell therapy
Industry: Drug Discovery Services

Beyond the preview

Go deeper on iPS Portal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iPS Portal.

Explore the full profile